Published 1982 | Version v1
Book

Imaging cholecystitis - Quo Vadis

  • 1. Christ Hospital, Oak Lawn, Illinois (U.S.A.)

Description

260 patients had sup(99m)Tc-HIDA (2,6,-dimethyl-acetanlide-iminodiacetic acid) or sup(99m)Tc-PIPIDA (p-isopropyl-acetanalide-iminodiacetic acid) cholescintiscans and cholecystosonograms from 4-1-78 to 10-31-81. 114 patients had gallblader surgery, and of these only 94 cases who showed common bile duct with spillage of activity into the intestines with or without gallbladder visualization in 60 minutes on cholescintigraphy were included in this study. The following results were emphasized: (1) cholescintiscans can be normal or abnormal in chronic cholecystitis. (2) A normal cholescintiscan rules out acute cholecystitis. (3) If acute cholecystitis is a differential consideration in the work-up of right upper quadrant pain, cholescintiscan is the imaging procedure of choice as a normal study excludes it. (4) An abnormal cholescintiscan is not pathognomonic of acute cholecystitis but does indicate a diseased gallbladder. (5) If the clinical diagnosis is acute or chronic cholecystitis, cholescintiscan is not recommended if cholecystosonogram shows cholelithiasis but may be indicated if stones are not present

Part of:
Nuclear medicine and biology

Additional details

Publishing Information

Publisher
Pergamon.
Imprint Place
Paris (France)
ISBN
0-08-027-090-5
Imprint Title
Nuclear medicine and biology
Imprint Pagination
1141 p.
Journal Page Range
v. 2 p. 2236-2239.

Conference

Title
3. World congress of nuclear medicine and biology.
Dates
29 Aug - 2 Sep 1982.
Place
Paris (France).

Optional Information